Dr. Ljubimov, Ph.D., D.Sc., FARVO, is an eye and cancer researcher specializing in ocular diabetes, retinal neovascularization, wound healing and nanomedicine. Director of Regenerative Medicine Institute Eye Program at Cedars-Sinai Medical Center, where he is also Professor of Biomedical Sciences and Neurosurgery. Long-time NIH grantee and member of 11 Editorial Boards.
work
Cedars-Sinai Medical Center
8700 Beverly Boulevard
AHSP A-8319
Los Angeles, CA 90048
Alexander V. Ljubimov is Director of Regenerative Medicine Institute Eye Program at Cedars-Sinai Medical Center and Professor of Medicine at the David Geffen School of Medicine at the University of California, Los Angeles.
Dr. Ljubimov is an internationally recognized eye researcher who has written many peer-reviewed papers, reviews, and book chapters. His primary research interests include investigating new promising inhibitors of a key cellular enzyme that block abnormal retinal vessel growth and using gene therapy to restore normal corneal structure and function in patients with diabetic retinopathy.
Dr. Ljubimov has been fully funded by NIH since 1998 (two current R01 grants). In 2006, he received a Winnick Family Clinical Research Scholar award from Cedars-Sinai. He has been serving on many NIH Study Sections and was a member of the American Diabetes Association Grant Review Panel. He is an editorial board member of 11 scientific journals.
Dr. Ljubimov received his master's of science degree from Moscow State University in Russia and received his PhD and D.Sc. degrees from the Russian Cancer Research Center. He completed postdoctoral training in the International Agency for Research on Cancer in Lyon, France. Before coming to Cedars-Sinai in 1993 he worked in the Burnham Institute in La Jolla, California, as a UICC-Eleanor Roosevelt Cancer Research Fellow.
Dr. Alexander Ljubimov is an internationally recognized eye researcher, with over 100 peer-reviewed papers, reviews, and book chapters published. He is Adjunct Professor of Medicine at the David Geffen School of Medicine at UCLA. Dr. Ljubimov is also Director of Regenerative Institute Eye Program at Cedars-Sinai Medical Center, and Professor of Biomedical Sciences and Neurosurgery. His research interests include using innovative gene and nano therapy to restore normal stem cell functions in diabetic corneas, and studying new inhibitors of a key cellular enzyme CK2 that block abnormal retinal vessel growth in diabetic retinopathy. He is involved in developing new targeted nanotherapeutics for cancer and eye diseases, and directs studies aiming at making corneal cells from induced pluripotent stem cells. Dr. Ljubimov's research has been funded by NIH since 1995 (with two current R01 grants). In 2006-2009, he was a recipient of the Winnick Family Clinical Research Scholar award from Cedars-Sinai Medical Center. He has served on numerous NIH Study Sections, was a member of the American Diabetes Association Grant Review Panel, and is a grant reviewer for various agencies in U.S. and abroad. He currently serves as a regular member on the NIH/NEI corneal Study Section. Dr. Ljubimov is an Editorial Board member of 13 scientific journals including Investigative Ophthalmology and Visual Science, Experimental Eye Research, Progress in Retinal and Eye Research, Molecular Vision, Brain Research Bulletin, Experimental Biology and Medicine, Scientific Reports, Conference Papers in Medicine, The Open Ophthalmology Journal, PLoS One, Cells, Current Gene Therapy and Frontiers in Bioscience. In 2010, he was named Silver Fellow of the Association for Research in Vision and Ophthalmology (ARVO), and Gold Fellow in 2014. In 2008-2010 he was an elected chair of the membership committee of the International Society for Eye Research. Dr. Ljubimov received his summa cum laude M.S. degree from Moscow State University (Moscow, Russia), and his Ph.D. and D.Sc. degrees from the Russian Cancer Research Center. He completed postdoctoral training in the International Agency for Research on Cancer in Lyon, France. Before coming to Cedars-Sinai Medical Center in 1993 he worked in the Sanford-Burnham Institute in La Jolla, California, as a UICC-Eleanor Roosevelt Cancer Research Fellow. He has a background in cancer research and is working on eye diseases since 1993.
Does this profile need updating? Contact Us